Ravelcare IPO: An Analysis
Ravelcare, a beauty and personal care brand, is planning to go public through an Initial Public Offering (IPO). The IPO will open for investment on December 1, 2025. Investors can purchase up to 1.9 million new shares, and it’s important to understand how this works.
Key Points
- Ravelcare IPO opens December 1, 2025, offering new shares.
- Price range: ₹123 to ₹130 per share – significant growth potential.
- Minimum investment: ₹260,000 (2 lots) for retail investors.
- HNI minimum: ₹390,000 (3 lots) or 3,000 shares – high-value options.
- IPO proceeds used for marketing and a new factory expansion.
- Listing expected on BSE SME platform by December 8, 2025.
Price and Lot Size: Ravelcare has set a price range for its IPO between ₹123 and ₹130 per share. The smallest amount an investor can bid for is 1,000 shares. A retail investor would need to invest at least ₹260,000 to buy two lots of shares – this is a substantial initial investment.
Timeline: The IPO subscription period will likely last three days, closing around Wednesday, December 3, 2025. After that, the company will decide who gets the shares (allotment) on Thursday, December 4, 2025. Finally, the shares are expected to be listed on the BSE SME platform on Monday, December 8, 2025.
How the Money is Used: Ravelcare plans to use the money raised from the IPO in two main ways. First, they’ll spend about ₹11.5 crore on advertising and promoting their brand. Second, they’ll invest ₹7.8 crore in building a new manufacturing plant in Amravati, Maharashtra.
Financial Performance: In the last year (FY25), Ravelcare’s sales increased by 13% to ₹24.97 crore. Their profits also grew, reaching ₹5.25 crore, showing a healthy business trajectory.
“This IPO represents a strong opportunity to participate in the growth of a successful beauty brand and supports its future expansion.”
